Trump’s new executive order promises to slash prescription drug prices by up to 80%, a move aimed at leveling the playing field for American consumers who’ve long paid more than the rest of the world.
Key Facts:
- President Trump announced he will sign an executive order aimed at slashing U.S. drug prices by 30% to 80%.
- The new rule establishes a “Most Favored Nation” policy so Americans pay no more than the lowest global price for the same drug.
- The order also addresses insulin, cancer medications, and epinephrine prices, reducing some costs to mere cents for qualifying patients.
- It builds on a prior executive order that standardized Medicare payments and could cut prices up to 60%.
- HHS Secretary Robert F. Kennedy Jr. will oversee feedback collection for Medicare Drug Price Negotiation policy reforms.
The Rest of The Story:
President Trump announced on Truth Social that a sweeping executive order will be signed to dramatically lower prescription drug prices in the U.S.
Citing years of disparity where Americans pay five to ten times more than other countries for identical drugs, Trump laid blame on pharmaceutical companies and political influence.
The order will anchor U.S. drug prices to the lowest prices available globally under a “Most Favored Nation” clause.
It also introduces measures to reduce costs on essential drugs like insulin and epinephrine, and empowers states to import cheaper alternatives when possible.
Trump emphasized that this action would not only save citizens money but also reduce overall national healthcare spending by trillions.
The astronomical price of prescription drugs has depleted savings accounts and crushed hardworking Americans.
The time for fairness and accountability is NOW.
Thank you @POTUS for taking decisive action to put the American People First! This is a HUGE WIN for Florida Seniors. pic.twitter.com/kiKHEC3Cxu
— Byron Donalds (@ByronDonalds) May 12, 2025
Commentary:
The reality for millions of Americans is harsh—life-saving drugs often come with impossible price tags.
Trump’s move to implement a “Most Favored Nation” policy strikes directly at the heart of a long-standing imbalance that has favored Big Pharma over the public.
Pharmaceutical companies have long defended their high U.S. prices by pointing to research and development costs, but that excuse has worn thin.
Other countries get the same drugs from the same manufacturers for a fraction of the price, leaving Americans to foot the bill.
This executive order is not only bold, it’s overdue.
Drug prices in the U.S. have risen at shocking rates, with nearly half of the increases outpacing inflation.
Americans, especially seniors and the uninsured, deserve protection from such abusive practices.
Trump’s plan tackles multiple angles: allowing price imports, adjusting Medicare pricing, and driving direct negotiations.
The focus on essential treatments like insulin and epinephrine reflects a compassionate understanding of daily American struggles.
The Bottom Line:
President Trump’s new executive order could radically reshape the American pharmaceutical market by cutting drug prices up to 80%.
If successful, it will bring long-awaited relief to millions of Americans crushed by rising healthcare costs.
With clear targets and aggressive reforms, this order may mark a turning point in the fight for fair drug pricing.
Read Next
– Obama Appointed Federal Judge Blocks Trump From Closing Three Key Federal Agencies
– 205 Arrested in Massive Child Predator Sting: FBI and DOJ Unleash “Operation Restore Justice”
– Trump Trolls Obama: Offers to ‘Fix’ Library ‘Disaster’
– Trump Admin Pulls Surgeon General Nomination At The Last Minute
– Another Federal Judge Blocks Trump, This Time Over COVID Related Aid to Schools
